Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Vanish and Woolite.
Market Cap: £44Billion
Reckitt Benckiser has had an indifferent few months. So often it’s a mainstay of investors portfolios with its predictable growth and solid stream of income. In recent months the share price has been in consolidation mode and not really offered investors very much. In recent weeks a has formed, and we are beginning to see investors return on spells of weakness. The latest move from the lower end of the channel could be the beginning of a fresh move higher towards resistance at 7175p
Target 1: 6710p
Target 2: 7165p
Interested in UK Stocks?
Join our free Telegram channel for up to date analysis on the best main market opportunities in the UK right now - https://t.me/UK_Stocks